Jianglong Hou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jianglong Hou has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Juelin Song
4 shared publications- Xuejie Li
Department of Anesthesiology, West China Hospital, Sichuan University and the Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu, China
4 shared publications Honghua Yue
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, People's Republic of China
3 shared publicationsJun Gu
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, People's Republic of China
2 shared publicationsMei Li
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China; West China School of Nursing, Sichuan University, Chengdu, Sichuan, PR China
2 shared publications- Peng Ji
Intensive Care Unit West China Hospital, Sichuan University Chengdu China
2 shared publications
Latest Publications
- 17 November 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (20) , 2001-2010
Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial
BACKGROUND: Guidelines recommend concomitant surgical ablation during cardiac surgery in patients with atrial fibrillation (AF). However, the optimal lesion set remains uncertain, with ongoing debate regarding the relative benefits and risks of biatrial versus left atrial (LA) maze ablation. METHODS: In this multicenter, randomized, single-blind trial, patients with persistent or long-standing persistent AF undergoing rheumatic mitral valve surgery, with or without concomitant cardiac surgical procedures, were randomly assigned in a 1:1 ratio to undergo biatrial or LA maze ablation. The biatrial group underwent a complete Cox-Maze IV procedure; the LA group received a left-sided maze lesion set. To ensure standardization and consistency of the ablation procedures, surgeons underwent pretrial training and certification, and all procedures were videorecorded and centrally reviewed. The primary outcome was freedom from atrial tachyarrhythmias lasting >30 seconds without antiarrhythmic drugs within 12 months. The key secondary end point was freedom from permanent pacemaker implantation. RESULTS: All 323 randomized patients were included in the intention-to-treat analysis (mean age, 56.5 years; 72.1% women; mean LA diameter, 51.9 mm). At 12 months, 78.7% of patients (129 of 164) in the biatrial group and 68.6% (109 of 159) in the LA group were free from atrial tachyarrhythmias (adjusted difference, 10.7% [1-sided lower 95% CI, 3%]; P =0.01). Freedom from permanent pacemaker implantation was noted in 97.0% (159 of 164) of the biatrial group and 98.1% (156 of 159) of the LA group, meeting the predefined noninferiority criterion with a margin of −5% (adjusted difference, –1.1% [1-sided lower 95% CI, –3.9%]; P noninferiority =0.01). CONCLUSIONS: Among patients with persistent or long-standing persistent AF undergoing rheumatic cardiac valve surgery, biatrial maze ablation was superior to LA maze ablation in reducing recurrent atrial tachyarrhythmias, while maintaining noninferiority with respect to permanent pacemaker implantation. These findings provide direct evidence to inform lesion-set selection for surgical ablation during cardiac surgery. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05021601.
- 17 November 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (20) , 2001-2010
Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial
BACKGROUND: Guidelines recommend concomitant surgical ablation during cardiac surgery in patients with atrial fibrillation (AF). However, the optimal lesion set remains uncertain, with ongoing debate regarding the relative benefits and risks of biatrial versus left atrial (LA) maze ablation. METHODS: In this multicenter, randomized, single-blind trial, patients with persistent or long-standing persistent AF undergoing rheumatic mitral valve surgery, with or without concomitant cardiac surgical procedures, were randomly assigned in a 1:1 ratio to undergo biatrial or LA maze ablation. The biatrial group underwent a complete Cox-Maze IV procedure; the LA group received a left-sided maze lesion set. To ensure standardization and consistency of the ablation procedures, surgeons underwent pretrial training and certification, and all procedures were videorecorded and centrally reviewed. The primary outcome was freedom from atrial tachyarrhythmias lasting >30 seconds without antiarrhythmic drugs within 12 months. The key secondary end point was freedom from permanent pacemaker implantation. RESULTS: All 323 randomized patients were included in the intention-to-treat analysis (mean age, 56.5 years; 72.1% women; mean LA diameter, 51.9 mm). At 12 months, 78.7% of patients (129 of 164) in the biatrial group and 68.6% (109 of 159) in the LA group were free from atrial tachyarrhythmias (adjusted difference, 10.7% [1-sided lower 95% CI, 3%]; P =0.01). Freedom from permanent pacemaker implantation was noted in 97.0% (159 of 164) of the biatrial group and 98.1% (156 of 159) of the LA group, meeting the predefined noninferiority criterion with a margin of −5% (adjusted difference, –1.1% [1-sided lower 95% CI, –3.9%]; P noninferiority =0.01). CONCLUSIONS: Among patients with persistent or long-standing persistent AF undergoing rheumatic cardiac valve surgery, biatrial maze ablation was superior to LA maze ablation in reducing recurrent atrial tachyarrhythmias, while maintaining noninferiority with respect to permanent pacemaker implantation. These findings provide direct evidence to inform lesion-set selection for surgical ablation during cardiac surgery. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05021601.
- Open Access
- 1 July 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (7) , 743
Mechanical versus bioprosthetic valves for tricuspid valve replacement in Chinese patients: a systematic review and meta-analysis
Background: Tricuspid valve replacement (TVR) is a critical intervention for severe tricuspid valve disease but carries high perioperative mortality. The optimal choice between mechanical and bioprosthetic valves remains controversial, and large-sample evidence specific to the Chinese population is lacking. This study aimed to systematically evaluate the clinical efficacy and safety of mechanical versus bioprosthetic valves in Chinese patients undergoing TVR. Methods: PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP (VIP Database), Chinese Biomedical Literature Database (CBM), and the Chinese Medical Journal Database were searched from inception to December 31, 2025. Eligible study types included randomized controlled trials, prospective or retrospective cohort studies, and case-control studies comparing mechanical and bioprosthetic valves in Chinese TVR patients; case reports, reviews, and conference abstracts were excluded. Participants were Chinese patients (including China’s mainland, Hong Kong, Macau, and Taiwan) undergoing TVR. The intervention of interest was TVR with a mechanical prosthesis versus a bioprosthesis. Risk of bias for cohort studies was assessed using the Newcastle-Ottawa Scale. Meta-analysis was performed with Review Manager 5.4.1, calculating relative risks for dichotomous outcomes and hazard ratios (HRs) for survival data. A fixed-effect model was used when I2Results: Eight retrospective cohort studies (1,504 patients: 537 mechanical, 967 bioprosthetic) were included. No statistically significant differences emerged between mechanical and bioprosthetic valves in early mortality [risk ratio (RR) 0.70, 95% confidence interval (CI): 0.48–1.02, P=0.06], long-term survival (HR 1.02, 95% CI: 0.57–1.84, P=0.94), or reoperation rate (RR 1.12, 95% CI: 0.61–2.05, P=0.72). Mechanical valves were associated with significantly higher risks of thromboembolic events (RR 2.09, 95% CI: 1.06–4.13, P=0.03) and bleeding events (RR 4.89, 95% CI: 3.12–7.72, PConclusions: In Chinese TVR patients, overall early and long‑term survival as well as reoperation rates do not differ significantly between mechanical and bioprosthetic valves when analyzed across heterogeneous populations. However, this finding does not imply that valve type is unimportant for individual patients. However, mechanical valves significantly increase postoperative thromboembolic and bleeding complications. Clinical decision-making should be individualized, considering patient age, life expectancy, anticoagulation adherence, and bleeding risk. For Chinese patients with good life expectancy and reliable anticoagulation access, mechanical valves remain an option; for those with poor adherence or high bleeding risk, bioprosthetic valves may be safer.
- 1 July 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (7) , 743
Open AccessMechanical versus bioprosthetic valves for tricuspid valve replacement in Chinese patients: a systematic review and meta-analysis
Background: Tricuspid valve replacement (TVR) is a critical intervention for severe tricuspid valve disease but carries high perioperative mortality. The optimal choice between mechanical and bioprosthetic valves remains controversial, and large-sample evidence specific to the Chinese population is lacking. This study aimed to systematically evaluate the clinical efficacy and safety of mechanical versus bioprosthetic valves in Chinese patients undergoing TVR. Methods: PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP (VIP Database), Chinese Biomedical Literature Database (CBM), and the Chinese Medical Journal Database were searched from inception to December 31, 2025. Eligible study types included randomized controlled trials, prospective or retrospective cohort studies, and case-control studies comparing mechanical and bioprosthetic valves in Chinese TVR patients; case reports, reviews, and conference abstracts were excluded. Participants were Chinese patients (including China’s mainland, Hong Kong, Macau, and Taiwan) undergoing TVR. The intervention of interest was TVR with a mechanical prosthesis versus a bioprosthesis. Risk of bias for cohort studies was assessed using the Newcastle-Ottawa Scale. Meta-analysis was performed with Review Manager 5.4.1, calculating relative risks for dichotomous outcomes and hazard ratios (HRs) for survival data. A fixed-effect model was used when I2Results: Eight retrospective cohort studies (1,504 patients: 537 mechanical, 967 bioprosthetic) were included. No statistically significant differences emerged between mechanical and bioprosthetic valves in early mortality [risk ratio (RR) 0.70, 95% confidence interval (CI): 0.48–1.02, P=0.06], long-term survival (HR 1.02, 95% CI: 0.57–1.84, P=0.94), or reoperation rate (RR 1.12, 95% CI: 0.61–2.05, P=0.72). Mechanical valves were associated with significantly higher risks of thromboembolic events (RR 2.09, 95% CI: 1.06–4.13, P=0.03) and bleeding events (RR 4.89, 95% CI: 3.12–7.72, PConclusions: In Chinese TVR patients, overall early and long‑term survival as well as reoperation rates do not differ significantly between mechanical and bioprosthetic valves when analyzed across heterogeneous populations. However, this finding does not imply that valve type is unimportant for individual patients. However, mechanical valves significantly increase postoperative thromboembolic and bleeding complications. Clinical decision-making should be individualized, considering patient age, life expectancy, anticoagulation adherence, and bleeding risk. For Chinese patients with good life expectancy and reliable anticoagulation access, mechanical valves remain an option; for those with poor adherence or high bleeding risk, bioprosthetic valves may be safer.
- 28 April 2024
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 110 (1) , 116285
Parvimonas micra-induced prosthetic valve endocarditis: a challenging case report and literature review
- 28 April 2024
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 110 (1) , 116285
Parvimonas micra-induced prosthetic valve endocarditis: a challenging case report and literature review
- 24 January 2024
- Published by Wiley in Echocardiography
- Vol. 41 (1) , e15741
Severe tricuspid regurgitation with chordae tendinae rupture in CABG surgery
A 58‐year‐old male patient was admitted with chest pain and was diagnosed with coronary heart disease. He was scheduled for coronary artery bypass grafting (CABG) under cardiopulmonary bypass (CPB). Intraoperative real‐time transesophageal echocardiography (TEE) showed that the tricuspid valves were well‐aligned and subtle regurgitation. Real‐time TEE after separation from CPB showed severe tricuspid regurgitation and prolapsed chordae tendineae. The tricuspid chordae tendineae rupture due to a right atrial venous return cannula. The use of negative pressure to improve venous drainage during CPB may result in the tricuspid valve being adsorbed to the cannula, increasing the likelihood of injury to the tricuspid valve.
- 24 January 2024
- Published by Wiley in Echocardiography
- Vol. 41 (1) , e15741
Severe tricuspid regurgitation with chordae tendinae rupture in CABG surgery
A 58‐year‐old male patient was admitted with chest pain and was diagnosed with coronary heart disease. He was scheduled for coronary artery bypass grafting (CABG) under cardiopulmonary bypass (CPB). Intraoperative real‐time transesophageal echocardiography (TEE) showed that the tricuspid valves were well‐aligned and subtle regurgitation. Real‐time TEE after separation from CPB showed severe tricuspid regurgitation and prolapsed chordae tendineae. The tricuspid chordae tendineae rupture due to a right atrial venous return cannula. The use of negative pressure to improve venous drainage during CPB may result in the tricuspid valve being adsorbed to the cannula, increasing the likelihood of injury to the tricuspid valve.
- Open Access
- 23 January 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 47 (5) , 2413-2414
3-day reversible spontaneous coma in an adult with valve replacement
- 23 January 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 47 (5) , 2413-2414
Open Access3-day reversible spontaneous coma in an adult with valve replacement
- 26 December 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 25 (5) , e160
The rare combination of pathologies: rheumatic mitral stenosis combined with supramitral ring
Xuejie Li, Jianglong Hou; The rare combination of pathologies: rheumatic mitral stenosis combined with supramitral ring, European Heart Journal - Cardiovascular
- 26 December 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 25 (5) , e160
The rare combination of pathologies: rheumatic mitral stenosis combined with supramitral ring
Xuejie Li, Jianglong Hou; The rare combination of pathologies: rheumatic mitral stenosis combined with supramitral ring, European Heart Journal - Cardiovascular
- 17 August 2023
- Published by Wiley in Echocardiography
- Vol. 40 (9) , 1021-1023
Atrial septal hematogenous cyst with calcification mimicking myxoma: A rare case
A 61-year-old female presented with right atrial mass during physical examination. Contrast-enhanced left heart echocardiography revealed a mass with the size of 32*23 mm in the right atrium, attached to the atrial septum; there was a certain degree of activity and deformation. MRI showed a mass of about 35*22 mm in the right atrium adjacent to the atrial septum, which was diagnosed with right atrial myxoma. Intraoperative TEE showed that the mass was located in the atrial septum close to the inferior vena cava and spontaneous echo contrast with hyperechoic images within the mass. The lesion was resected under cardiopulmonary bypass. Pathological examination revealed that the filling defect was an atrial septal hematogenous cyst with calcification.
- 17 August 2023
- Published by Wiley in Echocardiography
- Vol. 40 (9) , 1021-1023
Atrial septal hematogenous cyst with calcification mimicking myxoma: A rare case
A 61-year-old female presented with right atrial mass during physical examination. Contrast-enhanced left heart echocardiography revealed a mass with the size of 32*23 mm in the right atrium, attached to the atrial septum; there was a certain degree of activity and deformation. MRI showed a mass of about 35*22 mm in the right atrium adjacent to the atrial septum, which was diagnosed with right atrial myxoma. Intraoperative TEE showed that the mass was located in the atrial septum close to the inferior vena cava and spontaneous echo contrast with hyperechoic images within the mass. The lesion was resected under cardiopulmonary bypass. Pathological examination revealed that the filling defect was an atrial septal hematogenous cyst with calcification.
- Open Access
- 16 August 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (11) , 4966-4967
Metagenomic next-generation sequencing (mNGS)-assisted diagnosis of a case with infective endocarditis caused by Bartonella species
- 16 August 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (11) , 4966-4967
Open AccessMetagenomic next-generation sequencing (mNGS)-assisted diagnosis of a case with infective endocarditis caused by Bartonella species
- 8 July 2023
- Published by Wolters Kluwer Health in Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
- Vol. 52 (7) , 671-677
[Cardiac amyloidosis: pathological classification and clinical analysis of 48 cases].
Objective: To investigate the histological features and clinical manifestations in different types of cardiac amyloidosis to improve diagnostic accuracy. Methods: The histopathological features and clinical manifestations of 48 patients diagnosed with cardiac amyloidosis by Congo red stain and electron microscopy through endomyocardial biopsy were collected in West China Hospital of Sichuan University from January 2018 to December 2021. Immunohistochemical stains for immunoglobulin light chains (κ and λ) and transthyretin protein were carried out, and a review of literature was made. Results: The patients age ranged from 42 to 79 years (mean 56 years) and the male to female ratio was 1.1 to 1.0. The positive rate of endomyocardial biopsy was 97.9% (47/48), which was significantly higher than that of the abdominal wall fat (7/17). Congo red staining and electron microscopy were positive in 97.9% (47/48) and 93.5% (43/46), respectively. Immunohistochemical stains showed 32 cases (68.1%) were light chain type (AL-CA), including 31 cases of AL-λ type and 1 case of AL-κ type; 9 cases (19.1%) were transthyretin protein type (ATTR-CA); and 6 cases (12.8%) were not classified. There was no significant difference in the deposition pattern of amyloid between different types (P>0.05). Clinical data showed that ATTR-CA patients had less involvement of 2 or more organs and lower N-terminal pro-B-type natriuretic peptide (NT-proBNP) than the other type patients (PP6 000 ng/L, and troponin T >70 ng/L had a worse prognosis (P<0.05). Multivariate survival analysis showed that NT-proBNP and cardiac function grade were independent prognostic factors for cardiac amyloidosis patients. Conclusions: AL-λ is the most common type of cardiac amyloidosis in this group. Congo red staining combined with electron microscopy can significantly improve the diagnosis of cardiac amyloidosis. The clinical manifestations and prognosis of each type are different and can be classified based on immunostaining profile. However, there are still a few cases that cannot be typed; hence mass spectrometry is recommended if feasible.
- 8 July 2023
- Published by Wolters Kluwer Health in Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
- Vol. 52 (7) , 671-677
[Cardiac amyloidosis: pathological classification and clinical analysis of 48 cases].
Objective: To investigate the histological features and clinical manifestations in different types of cardiac amyloidosis to improve diagnostic accuracy. Methods: The histopathological features and clinical manifestations of 48 patients diagnosed with cardiac amyloidosis by Congo red stain and electron microscopy through endomyocardial biopsy were collected in West China Hospital of Sichuan University from January 2018 to December 2021. Immunohistochemical stains for immunoglobulin light chains (κ and λ) and transthyretin protein were carried out, and a review of literature was made. Results: The patients age ranged from 42 to 79 years (mean 56 years) and the male to female ratio was 1.1 to 1.0. The positive rate of endomyocardial biopsy was 97.9% (47/48), which was significantly higher than that of the abdominal wall fat (7/17). Congo red staining and electron microscopy were positive in 97.9% (47/48) and 93.5% (43/46), respectively. Immunohistochemical stains showed 32 cases (68.1%) were light chain type (AL-CA), including 31 cases of AL-λ type and 1 case of AL-κ type; 9 cases (19.1%) were transthyretin protein type (ATTR-CA); and 6 cases (12.8%) were not classified. There was no significant difference in the deposition pattern of amyloid between different types (P>0.05). Clinical data showed that ATTR-CA patients had less involvement of 2 or more organs and lower N-terminal pro-B-type natriuretic peptide (NT-proBNP) than the other type patients (PP6 000 ng/L, and troponin T >70 ng/L had a worse prognosis (P<0.05). Multivariate survival analysis showed that NT-proBNP and cardiac function grade were independent prognostic factors for cardiac amyloidosis patients. Conclusions: AL-λ is the most common type of cardiac amyloidosis in this group. Congo red staining combined with electron microscopy can significantly improve the diagnosis of cardiac amyloidosis. The clinical manifestations and prognosis of each type are different and can be classified based on immunostaining profile. However, there are still a few cases that cannot be typed; hence mass spectrometry is recommended if feasible.
- 4 May 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 24 (8) , e199
A rare case of left ventricular myxoma with LVIT and LVOT obstruction
We describe a case of a 74-year-old female patient who was admitted for episodes of syncope and was diagnosed with a left ventricular mass. The patient was scheduled to undergo left ventricular mass resection under median thoracotomy. Intraoperative transesophageal echocardiography (TEE) view showed the left ventricular mass, which was pushed into the left atrium during systole and blocked both the aortic valve and the left ventricular outflow tract (LVOT) (Panels A and B, Supplementary data online, Video). The left ventricular mass obstructs the left ventricular inflow tract (LVIT) during diastole, and adhesions to the mitral valve are severe (Panels C and D). A myxoid mass of the left ventricle was found to be close to the mitral valve (Panel E). Mitral valve replacement was performed because the mass was closely related to the mitral valve and it was difficult to separate the mitral valve. The postoperative pathological results suggested that the tumor was myxoma (Panel F). The patient was discharged 7 days later with a good prognosis. It is a rare case that left ventricular myxoma causes left ventricular inflow tract and left ventricular outflow tract obstruction simultaneously.
- 4 May 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 24 (8) , e199
A rare case of left ventricular myxoma with LVIT and LVOT obstruction
We describe a case of a 74-year-old female patient who was admitted for episodes of syncope and was diagnosed with a left ventricular mass. The patient was scheduled to undergo left ventricular mass resection under median thoracotomy. Intraoperative transesophageal echocardiography (TEE) view showed the left ventricular mass, which was pushed into the left atrium during systole and blocked both the aortic valve and the left ventricular outflow tract (LVOT) (Panels A and B, Supplementary data online, Video). The left ventricular mass obstructs the left ventricular inflow tract (LVIT) during diastole, and adhesions to the mitral valve are severe (Panels C and D). A myxoid mass of the left ventricle was found to be close to the mitral valve (Panel E). Mitral valve replacement was performed because the mass was closely related to the mitral valve and it was difficult to separate the mitral valve. The postoperative pathological results suggested that the tumor was myxoma (Panel F). The patient was discharged 7 days later with a good prognosis. It is a rare case that left ventricular myxoma causes left ventricular inflow tract and left ventricular outflow tract obstruction simultaneously.